Stockreport

Esperion (ESPR) Highlights Inclusion of Bempedoic Acid in 2026 ACC/AHA Dyslipidemia Guidelines [Yahoo! Finance]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF 16, 2026, Esperion highlighted the inclusion of bempedoic acid in the 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Manage [Read more]